Kincell Bio published a Quality Minute featuring Chief Quality Officer Melodie Bryce discussing the role of Quality in programs.
Public source
Publisher name
Public post
Does Quality slow things down? Or can it actually help programs move faster? In our latest Quality Minute, Melodie Bryce, Chief Quality Officer at Kincell Bio, challenge…
Company
Kincell Bio
Your CDMO Partner from Clinical to Commercial
- Industry
- Pharmaceutical Manufacturing
- Location
- Durham, US
- Company size
- 51–200 employees
About Kincell Bio
Tomorrow’s Cures. Developed. Delivered. Kincell Bio is a specialized cell therapy CDMO dedicated exclusively to advancing autologous and allogeneic cell therapies from early development through commercialization and commercial manufacturing. We partner closely with innovators to streamline CMC strategies, integrate process and analytical development, and deliver reliable, GMP-compliant manufacturing. Guided by our core pillars, Quality First, Better Science, Reliable Supply, Personalized Service, and Right Scale, we operate as an extension of our clients’ teams. With facilities in Gainesville, FL, and Research Triangle Park, NC, our dedicated experts support process development, assay optimization, clinical and pivotal manufacturing, and inspection readiness. At Kincell Bio, quality is embedded by design, enabling us to de-risk development, accelerate timelines, and help bring tomorrow’s cures to patients with confidence.
See moreLatest activity
Latest activity from Kincell Bio
9 signals
Presence & Recognition
Kincell Bio featured Melodie Bryce, Chief Quality Officer, on Biotech Leadership Conversations.
Presence & Recognition
Kincell Bio hosted an on-demand webinar titled Outsourced Pharma Cell Therapy Capabilities Update featuring Stewart McNaull, PhD, Chief Commercial Officer, and Matt Haines, Chief Operations Officer, discussing cell therapy CDMO considerations.
Presence & Recognition
Kincell Bio celebrated Labor Day with the team and their commitment to clients, colleagues, and patients.
Discover more
Similar signals
Similar public activity from other companies.
Presence & Recognition
AGC Biologics
AGC Biologics published an article in Fierce Biotech explaining the team's approach to risk assessment and process improvement in quality control and raw materials.
Presence & Recognition
OXB
OXB featured Ceri Schofield, VP, Head of Global Quality Projects and Performance, in an interview exploring how quality evolves from a compliance function into a strategic enabler for cell and gene therapy programmes.
Presence & Recognition
Patheon
Patheon featured Jennifer Cannon, Sector Commercial President, BioPharma Services, in a webinar hosted by Life Science Connect discussing onshoring strategies and flexible manufacturing models.
Presence & Recognition
eXmoor Pharma
eXmoor Pharma produced a short Q&A video featuring Senior Bio Manufacturing & Compliance Consultant and UK Qualified Person Drew Hope explaining why QP support extends into wider quality operations.
Presence & Recognition
Adare Pharma Solutions